Managing Partner and CEO of Back Bay Life Science Advisors |
Jonathan P. Gertler, MD is a Managing Partner and CEO of Back Bay Life Science Advisors and Managing Director, Bioventures Medtech Funds.
Dr. Gertler has over 35 years of clinical and scientific experience, and extensive advisory work with biotechnology, medical device, diagnostic, and health care IT companies in both the private and public sectors. He is a frequent speaker and writer on strategic issues facing life science companies at all stages and has founded several life sciences companies, including Antyllus Therapeutics; a development-stage biotechnology company focused on aortic diseases, and Optivio, a commercial-stage enterprise software platform for stress management and performance optimization. Dr. Gertler also founded Cardiovascular Technologies, an endovascular company that successfully exited in 2001. At Bridging the Gap 2022 Dr. Gertler will explain the differences among U.S. investor classes and how to prepare your company for on point discussion. Theme: Expanding to the U.S. |